fluocinolone acetonide
PolandDrugs containing this active substance
-
The medicine is used in adults and children (from 6 months of age) to treat acute otitis externa and bacterial otitis media in individuals with ventilation tubes.
Form: drops, ear solution in single-dose container
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios Salvat, S.A.
-
These drops are used in adults and children from 6 months of age for the treatment of acute bacterial otitis externa and otitis media (in persons with ear ventilation tubes).
Form: drops, ear solution
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios SALVAT, S.A.
-
The medicine is used in adults and children from 6 months of age for the treatment of acute otitis externa and otitis media (in patients with ventilation tubes) of bacterial origin.
Form: drops, ear solution
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios SALVAT, S.A.
-
The medicine is used in adults and children from 6 months of age for the treatment of acute bacterial otitis externa and otitis media (in persons with ear ventilation tubes).
Form: drops, ear solution
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios Salvat, S.A.
-
The medicine is used in adults and children (from 6 months of age) for the treatment of acute otitis externa and bacterial otitis media (in patients with ventilation tubes in the ear).
Form: drops, ear solution in single-dose container
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios Salvat, S.A.
-
The medicine is used to treat acute otitis externa and bacterial otitis media (in patients with ventilation tubes). It is intended for adults and children from 6 months of age.
Form: drops, ear solution
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios Salvat, S.A.
-
The medicine is used in adults and children from 6 months of age for the treatment of acute otitis externa and bacterial otitis media (in persons with ear ventilation tubes).
Form: drops, ear solution in single-dose container
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios Salvat, S.A.
-
The medicine is used in adults and children from 6 months of age for the treatment of acute bacterial otitis externa and otitis media (in patients with ventilation tubes).
Form: drops, ear solution
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios Salvat, S.A.
-
The medicinal product is used in adults and children from 6 months of age for the treatment of acute otitis externa and bacterial otitis media (in persons with ear ventilation tubes).
Form: drops, ear solution
Active substance Dosage ciprofloxacin 3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Laboratorios Salvat, S.A.
-
It is used in adults and children from 6 months of age to treat acute otitis externa and bacterial otitis media (in the presence of a ventilation tube in the ear).
Form: drops, ear solution
Active substance Dosage ciprofloxacin hydrochloride 3.3 mg/ml fluocinolone acetonide 0.25 mg/ml ATC: S02CA05
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicine is used topically for the treatment of acute and severe, non-infectious, dry skin inflammations, such as: seborrheic or atopic dermatitis, lichen nitidus, allergic contact eczema, erythema multiforme, lupus erythematosus, psoriasis (scalp or plaque), and lichen planus.
Form: gel
Active substance Dosage fluocinolone acetonide 0.25 mg ATC: D07AC04
Manufacturer: Jelfa Pharmaceutical Enterprise S.A.
-
The ointment is intended for the short-term treatment of acute and severe, dry skin inflammations that respond to glucocorticoids. It is used, among others, in seborrheic and atopic dermatitis, urticarial lichenoid dermatitis, contact eczema, erythema multiforme, lupus erythematosus, psoriasis, and lichen planus.
Form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC: D07AC04
Manufacturer: Bausch Health Ireland Limited
-
It is used for short-term, topical treatment of acute and severe, dry skin inflammations that cause persistent itching or excessive keratinization. It helps, among others, in seborrheic and atopic dermatitis, psoriasis, lichen planus, or contact dermatitis.
Form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC: D07AC04
Manufacturer: PharmaSwiss Czech Republic s.r.o.
-
The ointment is intended for short-term, topical treatment of acute and severe, dry skin inflammations that cause persistent itching or excessive keratinization. It is used, among others, in seborrheic dermatitis, atopic dermatitis, urticarial lichen planus, contact eczema, erythema multiforme, lupus erythematosus, psoriasis, and lichen planus.
Form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC: D07AC04
Manufacturer: Bausch Health Ireland Limited
-
The ointment is intended for short-term, topical treatment of acute and severe, non-infectious, dry skin inflammation that causes persistent itching or excessive keratinization. It is used, among others, in seborrheic dermatitis, atopic dermatitis, urticarial lichenoid dermatitis, contact eczema, psoriasis, or lichen planus.
Form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC: D07AC04
Manufacturer: Bausch Health Ireland Ltd.
-
The medicine is used topically to treat dry inflammatory skin conditions that respond to steroids and are complicated by bacterial infection. It helps, among others, in seborrheic and atopic dermatitis, lichen planus, contact eczema, psoriasis, and erythema multiforme.
Form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g neomycin sulfate 5 mg/g ATC: D07CC02
Manufacturer: Jelfa Pharmaceutical Enterprise S.A.
-
It is used in the treatment of vision loss caused by diabetic macular edema (when other methods are ineffective) and in the prevention of recurrent inflammation in the back of the eye.
Form: implant for vitreous body in applicator
Active substance Dosage fluocinolone acetonide 0.19 mg ATC: S01BA15
Manufacturer: Millmount Healthcare Limited